On today's episode we are joined by Dr Tuzer Kalkan, a postdoctoral researcher at the Cambridge Stem Cell Institute!

On today's episode we are joined by Dr Tuzer Kalkan, a postdoctoral researcher at the Cambridge Stem Cell Institute!

On this week episode of Stem Cells at Lunch digested we have with us Dr Su Lwin, who is a trained medical doctor currently doing her PhD here at King's College London!

On this week episode of Stem Cells at Lunch digested we have with us Dr Su Lwin, who is a trained medical doctor currently doing her PhD here at King's College London!

Charles Fracchia is the founder and CEO of BioBright, a company building the smart lab to improve reproducibility in bio-medical research. He is interested in how artificial intelligence, automation and human-computer interfaces can improve the human ability to do research. He completed his bachelors in biology at Imperial College, his masters between the MIT Media Lab and Harvard Medical School. In 2016, Charles was named one of 35 innovators under 35 by the MIT Technology Review. He is the recipient of several awards including IBM PhD fellowships, an Extraordinary Minds fellowship, one of the first Awesome Foundation fellowships and an Amplify Partners fellowship. He is the author of several patents and is actively authoring more in the field of future laboratory tools. Charles has also been involved in obtaining numerous grants and contracts from DARPA, NSF, Google X, Knight Foundation and the Shanghai High Tech Incubator totaling several millions since 2012.

Charles Fracchia is the founder and CEO of BioBright, a company building the smart lab to improve reproducibility in bio-medical research. He is interested in how artificial intelligence, automation and human-computer interfaces can improve the human ability to do research. He completed his bachelors in biology at Imperial College, his masters between the MIT Media Lab and Harvard Medical School. In 2016, Charles was named one of 35 innovators under 35 by the MIT Technology Review. He is the recipient of several awards including IBM PhD fellowships, an Extraordinary Minds fellowship, one of the first Awesome Foundation fellowships and an Amplify Partners fellowship. He is the author of several patents and is actively authoring more in the field of future laboratory tools. Charles has also been involved in obtaining numerous grants and contracts from DARPA, NSF, Google X, Knight Foundation and the Shanghai High Tech Incubator totaling several millions since 2012.

To celebrate the International Day of women and girls in science , in this week’s podcast we have Dr Sara-Jane Dunn. Sara is a scientist based within the Biological Computation group at Microsoft Research Cambridge, and an affiliate researcher at the Wellcome Trust – Medical Research Council Stem Cell Institute, University of Cambridge. She trained as a mathematician and got a PhD in Computer Science from the University of Oxford. Currently Sara-Jane works at the interface between mathematics, computer science and biology, specifically developing a theory of biology as computation, in which the biochemistry of the cell performs information processing in the service of decision-making. To fulfil her goal she collaborates with research experimentalists at the Universities of Cambridge and Padova to investigate stem cell decision-making throughout Development. The goal of her research is ultimately to make cells programmable, which could fundamentally transform medicine, agriculture and even the ways we generate energy.

To celebrate the International Day of women and girls in science , in this week’s podcast we have Dr Sara-Jane Dunn. Sara is a scientist based within the Biological Computation group at Microsoft Research Cambridge, and an affiliate researcher at the Wellcome Trust – Medical Research Council Stem Cell Institute, University of Cambridge. She trained as a mathematician and got a PhD in Computer Science from the University of Oxford. Currently Sara-Jane works at the interface between mathematics, computer science and biology, specifically developing a theory of biology as computation, in which the biochemistry of the cell performs information processing in the service of decision-making. To fulfil her goal she collaborates with research experimentalists at the Universities of Cambridge and Padova to investigate stem cell decision-making throughout Development. The goal of her research is ultimately to make cells programmable, which could fundamentally transform medicine, agriculture and even the ways we generate energy.

Today at Stem Cells @Lunch Digested we have Prof Ian MacKenzie. Ian is Professor of Stem Cell Science at the Blizzard Institute, part of Queen Mary University of London. His research interests are the cellular mechanisms involved in the maintenance of skin and oral mucosa; stem cells; tissue renewal; and cancer.

Today at Stem Cells @Lunch Digested we have Prof Ian MacKenzie. Ian is Professor of Stem Cell Science at the Blizzard Institute, part of Queen Mary University of London. His research interests are the cellular mechanisms involved in the maintenance of skin and oral mucosa; stem cells; tissue renewal; and cancer.